PRINCETON, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the ...

On Thursday, Anthropic announced Claude 3.5 Sonnet, its latest AI language model and the first in a new series of “3.5” models that build upon Claude 3, launched in March. Claude 3.5 can compose text, ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now A new large language model (LLM) has ...

Sonnet BioTherapeutics Holdings, Inc. announced that its abstract has been accepted for a poster presentation at the 2025 American Association for Cancer Research (AACR) IO Conference, scheduled for ...

Sonnet BioTherapeutics (NASDAQ:SONN) stock is falling on Wednesday after the biotechnology company revealed details of a public share offering. That public stock offering has Sonnet BioTherapeutics ...

Anthropic, the main commercial competitor to OpenAI and Google in closed-source generative artificial intelligence, on Thursday unveiled the latest generation of its large language model (LLM) family, ...

- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 This press release contains certain ...